Bio-Thera Solutions, Ltd. (SHA:688177)
23.70
-0.16 (-0.67%)
At close: Feb 13, 2026
Bio-Thera Solutions Revenue
Bio-Thera Solutions had revenue of 241.70M CNY in the quarter ending September 30, 2025, with 34.92% growth. This brings the company's revenue in the last twelve months to 845.32M, up 2.44% year-over-year. In the year 2024, Bio-Thera Solutions had annual revenue of 743.17M with 5.44% growth.
Revenue (ttm)
845.32M
Revenue Growth
+2.44%
P/S Ratio
11.61
Revenue / Employee
675.72K
Employees
1,266
Market Cap
9.81B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 743.17M | 38.37M | 5.44% |
| Dec 31, 2023 | 704.79M | 249.66M | 54.86% |
| Dec 31, 2022 | 455.13M | -381.45M | -45.60% |
| Dec 31, 2021 | 836.58M | 653.72M | 357.49% |
| Dec 31, 2020 | 182.86M | 182.16M | 26,023.37% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chengzhi | 11.53B |
| Youcare Pharmaceutical Group | 2.55B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 1.90B |
| Aurisco Pharmaceutical | 1.62B |
| Liaoning Chengda Biotechnology | 1.47B |
| Chengdu Kanghua Biological Products | 1.21B |
| Jiangxi Fushine Pharmaceutical | 970.32M |
| Daan Gene | 765.48M |